Clinical Trial Update: AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study

View source ↗

Summary

Completed ancillary study to AREDS 2 using spectral-domain optical coherence tomography to evaluate imaging in age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: Duke University | Conditions: Age Related Macular Degeneration | Status: COMPLETED